Barron's Sees Opportunity in Health-Care, Likes Baxter (BAX)
Get Alerts BAX Hot Sheet
Price: $23.68 +3.27%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
Revenue Growth %: +2.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
Revenue Growth %: +2.5%
Join SI Premium – FREE
Barron's sees opportunity in health-care shares, as many investors have written them off for dead. Barron's notes the Standard & Poor's 500's health-care sector trades below 12x earnings for the next 12 months and for calendar 2010. This versus more than 14x for the whole S&P.
Barron's highlighted Baxter International (NYSE: BAX) in particular, saying it offers modest valuation, healthy growth prospects and insulation from possible reform measures.
Link to Barron's Article $
Barron's highlighted Baxter International (NYSE: BAX) in particular, saying it offers modest valuation, healthy growth prospects and insulation from possible reform measures.
Link to Barron's Article $
You May Also Be Interested In
- Microsoft to consider shareholder proposals through 2027, even as SEC proposes to end oversight of such votes - Reuters
- Live Oak Acquisition Corp. VI prices $200M IPO on Nasdaq
- Domo sells assets to Progress Software, renames itself Huckleberry.ai
Create E-mail Alert Related Categories
Insiders' BlogRelated Entities
Standard & Poor's, Barron'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share